The role of diffusion-weighted MRI and contrast-enhanced MRI for differentiation between solid renal masses and renal cell carcinoma subtypes
Purpose To assess the value of diffusion-weighted magnetic resonance imaging (DW-MRI) and contrast-enhanced MRI (CE-MRI) for differentiation between benign and malignant solid renal masses, renal cell carcinoma (RCC) subtypes, oncocytomas, and lipid-poor angiomyolipomas (LP-AML). Methods Minimum or lowest ‘apparent diffusion coefficient’ ($ ADC_{1} $) and representative ADC values ($ ADC_{2} $) of 112 renal masses (n: 46 benign renal mass, n: 66 malignant renal mass) were measured on DW-MRI images (b 50, 400, 800 s/$ mm^{2} $). Signal intensity (SI) measurements were performed in normal renal parenchyma and most avid enhanced area of the renal masses at precontrast, corticomedullary, and nephrographic phases on CE-MRI. Contrast enhancement rate (CER) and contrast enhancement index (CEI) values of renal masses were compared between benign-malignant renal masses and RCC subtypes, oncocytomas, and LP-AMLs. Results There was no significant difference between $ ADC_{1} $, $ ADC_{2} $ values, and SI of benign and malignant renal masses (p = 0.721, p = 0.255, p = 0.872). Mean $ ADC_{1} $ and $ ADC_{2} $ values of clear cell RCCs were significantly higher than nonclear cell RCCs (p = 0.005 p = 0.002). Mean CER value of clear cell RCCs was significantly higher than nonclear cell RCCs in nephrographic phase (p = 0.003). Mean CEI values of clear cell RCCs were significantly higher than nonclear cell RCCs in the corticomedullary and nephrographic phase (p = 0.027 vs. 0.008). LP-AMLs were differentiated from other renal masses with wash-out phenomenon. Conclusion Combined usage of ADC, SI, CER, and CEI values may be useful for discrimination between RCC subtypes, oncocytomas, and lipid-poor AMLs..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:46 |
---|---|
Enthalten in: |
Abdominal radiology - 46(2020), 3 vom: 15. Sept., Seite 1041-1052 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Serter, Aslı [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
Themen: |
Benign neoplasms |
---|
doi: |
10.1007/s00261-020-02742-w |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR043425615 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR043425615 | ||
003 | DE-627 | ||
005 | 20230519075909.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210309s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s00261-020-02742-w |2 doi | |
035 | |a (DE-627)SPR043425615 | ||
035 | |a (DE-599)SPRs00261-020-02742-w-e | ||
035 | |a (SPR)s00261-020-02742-w-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q ASE |
082 | 0 | 4 | |a 610 |q ASE |
100 | 1 | |a Serter, Aslı |e verfasserin |4 aut | |
245 | 1 | 4 | |a The role of diffusion-weighted MRI and contrast-enhanced MRI for differentiation between solid renal masses and renal cell carcinoma subtypes |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Purpose To assess the value of diffusion-weighted magnetic resonance imaging (DW-MRI) and contrast-enhanced MRI (CE-MRI) for differentiation between benign and malignant solid renal masses, renal cell carcinoma (RCC) subtypes, oncocytomas, and lipid-poor angiomyolipomas (LP-AML). Methods Minimum or lowest ‘apparent diffusion coefficient’ ($ ADC_{1} $) and representative ADC values ($ ADC_{2} $) of 112 renal masses (n: 46 benign renal mass, n: 66 malignant renal mass) were measured on DW-MRI images (b 50, 400, 800 s/$ mm^{2} $). Signal intensity (SI) measurements were performed in normal renal parenchyma and most avid enhanced area of the renal masses at precontrast, corticomedullary, and nephrographic phases on CE-MRI. Contrast enhancement rate (CER) and contrast enhancement index (CEI) values of renal masses were compared between benign-malignant renal masses and RCC subtypes, oncocytomas, and LP-AMLs. Results There was no significant difference between $ ADC_{1} $, $ ADC_{2} $ values, and SI of benign and malignant renal masses (p = 0.721, p = 0.255, p = 0.872). Mean $ ADC_{1} $ and $ ADC_{2} $ values of clear cell RCCs were significantly higher than nonclear cell RCCs (p = 0.005 p = 0.002). Mean CER value of clear cell RCCs was significantly higher than nonclear cell RCCs in nephrographic phase (p = 0.003). Mean CEI values of clear cell RCCs were significantly higher than nonclear cell RCCs in the corticomedullary and nephrographic phase (p = 0.027 vs. 0.008). LP-AMLs were differentiated from other renal masses with wash-out phenomenon. Conclusion Combined usage of ADC, SI, CER, and CEI values may be useful for discrimination between RCC subtypes, oncocytomas, and lipid-poor AMLs. | ||
650 | 4 | |a Kidney |7 (dpeaa)DE-He213 | |
650 | 4 | |a Diffusion-weighted MRI |7 (dpeaa)DE-He213 | |
650 | 4 | |a Magnetization transfer contrast imaging |7 (dpeaa)DE-He213 | |
650 | 4 | |a Benign neoplasms |7 (dpeaa)DE-He213 | |
650 | 4 | |a Malignant neoplasms |7 (dpeaa)DE-He213 | |
700 | 1 | |a Onur, Mehmet Ruhi |e verfasserin |4 aut | |
700 | 1 | |a Coban, Ganime |e verfasserin |4 aut | |
700 | 1 | |a Yildiz, Pelin |e verfasserin |4 aut | |
700 | 1 | |a Armagan, Abdullah |e verfasserin |4 aut | |
700 | 1 | |a Kocakoc, Ercan |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Abdominal radiology |d [Boston, MA] : Springer US, 2016 |g 46(2020), 3 vom: 15. Sept., Seite 1041-1052 |w (DE-627)SPR003173186 |w (DE-600)2845742-0 |x 2366-0058 |7 nnns |
773 | 1 | 8 | |g volume:46 |g year:2020 |g number:3 |g day:15 |g month:09 |g pages:1041-1052 |
856 | 4 | 0 | |u https://dx.doi.org/10.1007/s00261-020-02742-w |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_SPRINGER | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |d 46 |j 2020 |e 3 |b 15 |c 09 |h 1041-1052 |